Lamotrigine Viatris (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels on neurons, which stabilises the neuronal membrane and reduces the release of excitatory neurotransmitters such as glutamate, thereby decreasing seizure activity and mood instability.

The dosage of Lamotrigine Viatris is determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and any concomitant medications. Patients should follow the prescriber’s specific instructions.

Safety data for lamotrigine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamotrigine offers a broad spectrum of seizure control and mood‑stabilising properties, with a relatively favourable side‑effect profile compared with some older anticonvulsants. However, drug‑specific factors such as interaction potential, individual tolerability and therapeutic goals influence the choice of therapy.

Lamotrigine Viatris should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight to maintain product stability.

Lamotrigine Viatris is taken orally, usually as a tablet, with or without food as directed by the prescriber. The tablet should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, aseptic meningitis, and blood dyscrasias like agranulocytosis. Prompt medical attention is required if any signs of these conditions appear.

Lamotrigine Viatris is contraindicated in patients with a known hypersensitivity to lamotrigine or any component of the formulation. Caution is also advised for individuals with severe hepatic or renal impairment, and those taking interacting medications without appropriate monitoring.